Serum Protein Research Articles

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway.

We aimed to delve into the mechanisms underpinning Jiawei Shengjiang San's (JWSJS) action in treating diabetic nephropathy and deploying network pharmacology. Employing network pharmacology and molecular docking techniques, we predicted the active components and targets of JWSJS and constructed a meticulous "drug-component-target" network. Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were utilized to discern the therapeutic pathways and targets of JWSJS. Autodock Vina 1.2.0 was deployed for molecular docking verification, and a 100-ns molecular dynamics simulation was conducted to affirm the docking results, followed by in vivo animal verification. The findings revealed that JWSJS shared 227 intersecting targets with diabetic nephropathy, constructing a protein-protein interaction network topology. KEGG enrichment analysis denoted that JWSJS mitigates diabetic nephropathy by modulating lipids and atherosclerosis, the PI3K-Akt signaling pathway, apoptosis, and the HIF-1 signaling pathway, with mitogen-activated protein kinase 1 (MAPK1), MAPK3, epidermal growth factor receptor (EGFR), and serine/threonine-protein kinase 1 (AKT1) identified as collective targets of multiple pathways. Molecular docking asserted that the core components of JWSJS (quercetin, palmitoleic acid, and luteolin) could stabilize conformation with three pivotal targets (MAPK1, MAPK3, and EGFR) through hydrogen bonding. In vivo examinations indicated notable augmentation in body weight and reductions in glycated serum protein (GSP), low-density lipoprotein cholesterol (LDL-C), uridine triphosphate (UTP), and fasting blood glucose (FBG) levels due to JWSJS. Electron microscopy coupled with hematoxylin and eosin (HE) and Periodic acid-Schiff (PAS) staining highlighted the potential of each treatment group in alleviating kidney damage to diverse extents, exhibiting varied declines in p-EGFR, p-MAPK3/1, and BAX, and increments in BCL-2 expression in the kidney tissues of the treated rats. Conclusively, these insights suggest that the protective efficacy of JWSJS on diabetic nephropathy might be associated with suppressing the activation of the EGFR/MAPK3/1 signaling pathway and alleviating renal cell apoptosis.

Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis.

Response to biologics in psoriasis varies in real-world settings. Serum biomarkers could aid biologic selection and dose modifications to improve patient outcomes while encouraging cost-effective care. To explore the exposure-response relationship for guselkumab (GUS), to define a GUS concentration target for optimal response and to evaluate the potential of serum protein levels as predictive biomarker candidates. This is a prospective, multicentric, cohort study in psoriasis patients treated with GUS. Serum GUS trough concentrations (TCs) collected at multiple timepoints were measured using an in-house immunoassay. Next, proximity extension assay technology (Target 96 Inflammation Panel Olink®) was used to measure serum protein levels in a subcohort including 38 GUS patients (week 0 and week 4), six psoriasis patients naive for systemic treatment and four healthy controls. Seventy-five patients participated and 400 samples were collected. Guselkumab TCs and clinical response were correlated at week 4, week 12 and in steady-state (≥20 weeks). Optimal responders (Psoriasis Area and Severity Index [PASI] ≤ 2) had significantly higher TCs than suboptimal responders from week 4 onwards in treatment. An optimal steady-state TC of 1.6 μg/mL was defined. Although TC and absolute PASI were lower and worse, respectively, in patients weighing ≥90 kg, clinical outcomes referred to desirable to excellent PASI ranges. Therefore, we do not recommend systematically higher GUS doses in obese patients. We could not reveal early differentially expressed proteins to distinguish future optimal from suboptimal responders. We demonstrated an exposure-response relationship for GUS and an optimal steady-state TC of 1.6 μg/mL in real-world psoriasis patients. Hereby, we deliver more evidence that therapeutic drug monitoring poses a promising strategy in optimizing GUS treatment. No biomarker candidates were identified through serum proteomics. We propose protein screening should be repeated in larger cohorts to continue the quest for predictive biomarkers.

Estimation of Total Proteins and Minerals Content of Bovine Brucellosis and Anaplasmosis in Some Local Dairy Farms in Kosti, Sudan

Bovine brucellosis, caused by Brucella abortus, is a significant bacterial infectious zoonotic disease not only poses a threat to animal health but also presents economic challenges and public health concerns due to its potential transmission to humans. Humans can contract the disease through direct contact with infected animals or consumption of unpasteurized dairy products. Bovine anaplasmosis is a haemolytic disease of cattle caused by the bacterium Anaplasma marginale which can cause adult mortality, abortion, weight loss, and a reduction in performance. This paper described the results obtained from the effects of brucellosis and anaplasmosis on serum proteins and the level of the macro elements (Calcium, Phosphorus, Potassium, Sodium, and Magnesium). These minerals play an essential role in animal metabolism. Out of fourteen Bovine serum samples, five samples were found to be positive for Brucella (35.72%) and four samples were found to be positive for Anaplasma (28.57%), the remaining samples were negative. Total protein (Tb) and (Alb) levels were significantly increased (P<0.01) in both brucellosis and anaplasmosis cattle compared with controls. On the other hand Globulin (Glob) was significantly decreased (P<0.01) in brucellosis cattle compared to the controls, also the present study showed that, concentration of Na, Ca, and Mg minerals were significantly increased in case of Brucellosis compared to the controls and significantly low (P<0.05) in potassium level, while animals infected with anaplasmosis showed an increased level of Na and K and decreased level in Mg. In summary, comprehension of laboratory medicine parameters is crucial for monitoring animal health and diagnosing diseases like brucellosis and anaplasmosis. These parameters are essential for implementing effective control measures and ensuring livestock well-being. The objective of this study was to estimate the total proteins and minerals content of Bovine Brucellosis and Anaplasmosis in ...

GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians.

Diabetes mellitus (DM) is a chronic disorder that affects nearly half a billion people around the world and causes millions of deaths annually. Treatment of diabetes or related complications represents an economic burden not only for developing countries but also for the developed ones. Hence, new efficient therapeutic and preventive strategies and screening tools are necessary. The current work aimed to assess the potential association of single nucleotide polymorphisms (SNPs) in ghrelin O-acyltransferase (GOAT) rs10096097, cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) rs6740584, and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA) rs62521874 genes with type 2 DM susceptibility in Egyptians. A total of 96 patients with type 2 DM along with 72 healthy individuals participated in this study. Genotyping was executed via real-time polymerase chain reaction (PCR), and the serum protein levels of GOAT, CREB, and MafA were measured by enzyme-linked immunosorbent assay (ELISA). Genotyping revealed a significant association of GOAT rs10096097 and CREB1 rs6740584 SNPs with type 2 diabetes risk, with significantly higher GOAT rs10096097 G allele and CREB1 rs6740584 T allele frequencies in diabetic patients than in controls. However, insignificant association was identified between the MafA rs62521874 SNP and diabetes in the examined sample of the Egyptian residents. Serum GOAT, CREB1, and MafA protein levels did not vary significantly between diabetic and control individuals. Yet, significant variation in serum GOAT and CREB1 levels was detected between CREB1 rs6740584 genotypes within the diabetic group, with CT and TT genotype carriers showing higher levels than AA genotype patients. GOAT rs10096097 and CREB1 rs6740584, but not MafA rs62521874, SNPs are associated with type 2 diabetes risk in the studied Egyptians.

Hypercalcaemia in a dog with hypothyroidism

AbstractA 5‐year‐old, entire, female Greenland dog was presented with polyuria and polydipsia. A mildly increased circulating concentration of ionised calcium, mild non‐regenerative anaemia, mild hypercholesterolemia and mild increases in liver enzyme activity were detected. Parathyroid hormone, plasma parathyroid hormone‐related protein and vitamin D were analysed in a blood sample, with all results below the lower limit of the reference range. Further investigation with abdominal ultrasonography, fine‐needle aspiration for cytology of the liver and spleen, thoracic radiography, adrenocorticotropic hormone‐stimulation and serum protein electrophoresis could not detect any disease. During the next months, the dog developed coat changes that clinically corresponded to an endocrinopathy. Analysis of thyroxine and thyroid‐stimulating hormone was performed. Thyroxine was less than 6 nmol/L and thyroid‐stimulating hormone was 1.5 µg/L, which indicated primary hypothyroidism. Treatment with l‐thyroxine resulted in normalisation of the hypercalcaemia. Moreover, the polyuria and alopecia resolved.

Assessment of glial fibrillary acidic protein and anti-glial fibrillary acidic protein autoantibody concentrations and necrotising meningoencephalitis risk genotype in dogs with pug dog myelopathy.

Pugs commonly present with thoracolumbar myelopathy, also known as pug dog myelopathy (PDM), which is clinically characterised by progressive signs involving the pelvic limbs, no apparent signs of pain and, often, incontinence. In addition to meningeal fibrosis and focal spinal cord destruction, histopathology has confirmed lymphohistiocytic infiltrates in the central nervous system (CNS) in a considerable number of pugs with PDM. Lymphohistiocytic CNS inflammation also characterises necrotising meningoencephalitis (NME) in pugs. This study aimed to investigate the potential contribution of an immunological aetiology to the development of PDM. The concentrations of glial fibrillary acidic protein (GFAP) in serum and CSF and of anti-GFAP autoantibodies in CSF were measured with an ELISA. In addition, a commercial test was used for genetic characterisation of the dog leukocyte antigen class II haplotype, which is associated with NME susceptibility. This study included 87 dogs: 52 PDM pugs, 14 control pugs, four NME pugs and 17 dogs of breeds other than pugs that were investigated for neurological disease (neuro controls). Anti-GFAP autoantibodies were present in 15 of 19 (79%) of the PDM pugs tested versus six of 16 (38%) of the neuro controls tested (p = 0.018). All 18 PDM pugs evaluated had detectable CSF GFAP. Serum GFAP was detected in two of three (67%) of the NME pugs and in two of 11 (18%) of the control pugs but not in any of the 40 tested PDM pugs. Male pugs heterozygous for the NME risk haplotype had an earlier onset of clinical signs (70 months) compared to male pugs without the risk haplotype (78 months) (p = 0.036). The study was limited bythe lack of healthy dogs of breeds other than pugs and the small numbers of control pugs and pugs with NME. The high proportion of PDM pugs with anti-GFAP autoantibodies and high CSF GFAP concentrations provide support for a potential immunological contribution to the development of PDM.

A Cell-Based Assay to Measure the Activity of the Complement Convertases

IntroductionThe complement system serves as a crucial defense mechanism against invading pathogens, but dysregulation of this system can result in harmful consequences. Central to the complement cascade are the classical/lectin and the alternative pathway convertases. Aberrant regulation of the convertases is often implicated in the development of rare complement-related diseases. However, analyzing convertase activity poses a significant challenge due to their labile nature and intricate interactions with serum proteins. MethodsIn this study, we propose a novel assay for the functional evaluation of these complexes. Our approach leverages a widely available human lymphoma cell line, which, when sensitized with antibodies, triggers activation of the classical pathway with a substantial amplification by the alternative pathway. The combined action of two C5 blockers eculizumab and crovalimab let the cascade proceed up to the level of convertases but not further. In the next step, C5 inhibitors are washed away and guinea pig serum in EDTA buffer supports the development of lytic sites on the platform of pre-existing convertases. ResultsThe assay detects recombinant gain-of-function components of both convertase types within human serum or plasma. Furthermore, we demonstrate the assay's practical utility in analyzing nephrological patients harboring C3 genetic variants and illustrate its capacity to distinguish between patients and asymptomatic relatives carrying the same pathogenic C3 variant. ConclusionsWe provided a proof of concept of a new assay that detects convertase overactivity in individuals carrying variants of both pathogenic character or these of unknown significance in ubiquitous complement proteins like C3.

Cytosolic sulfotransferases in endocrine disruption.

The mammalian cytosolic sulfotransferases (SULTs) catalyze the sulfation of endocrine hormones as well as a broad array of drugs, environmental chemicals, and other xenobiotics. Many endocrine-disrupting chemicals (EDCs) interact with these SULTs as substrates and inhibitors, and thereby alter sulfation reactions responsible for metabolism and regulation of endocrine hormones such as estrogens and thyroid hormones. EDCs or their metabolites may also regulate expression of SULTs through direct interaction with nuclear receptors and other transcription factors. Moreover, some sulfate esters derived from EDCs (EDC-sulfates) may serve as ligands for endocrine hormone receptors. While the sulfation of an EDC can lead to its excretion in the urine or bile, it may also result in retention of the EDC-sulfate through its reversible binding to serum proteins and thereby enable transport to other tissues for intracellular hydrolysis and subsequent endocrine disruption. This mini-review outlines the potential roles of SULTs and sulfation in the effects of EDCs and our evolving understanding of these processes.

Methscore: a comprehensive R function for DNA methylation-based health predictors.

DNA methylation-based predictors of various biological metrics have been widely published and are becoming valuable tools in epidemiologic studies of epigenetics and personalized medicine. However, generating these predictors from original source software and web servers is complex and time consuming. Furthermore, different predictors were often derived based on data from different types of arrays, where array differences and batch effects can make predictors difficult to compare across studies. We integrate these published methods into a single R function to produce 158 previously published predictors for chronological age, biological age, exposures, lifestyle traits and serum protein levels using both classical and principal component-based methods. To mitigate batch and array differences, we also provide a modified RCP method (ref-RCP) that normalize input DNA methylation data to reference data prior to estimation. Evaluations in real datasets show that this approach improves estimate precision and comparability across studies. The function was included in software package ENmix, and is freely available from Bioconductor website (https://www.bioconductor.org/packages/release/bioc/html/ENmix.html).

Uncommon detection of monoclonal proteins in alpha 2 region on serum protein electrophoresis: A case series

Uncommon detection of monoclonal proteins in alpha 2 region on serum protein electrophoresis: A case series

Bisalbuminemia: A rare discovery during serum protein electrophoresis

Bisalbuminemia: A rare discovery during serum protein electrophoresis

Ustekinumab in serum protein electrophoresis: Defining forthcoming potential artifacts

Ustekinumab in serum protein electrophoresis: Defining forthcoming potential artifacts

Serum-Derived Bovine Immunoglobulin/Protein Isolate Bind Aflatoxins B2 and G1

Aflatoxins are highly toxic biproducts of mold growth which commonly contaminate agricultural commodities, including food and feed. The United States Centers for Disease Control and Prevention estimates approximately half of people worldwide are chronically exposed to aflatoxins through their regular food consumption. The gut serves as both the initial target of toxicity and the location of absorption, leading to systemic exposure. Serum-derived bovine immunoglobulin/protein isolate (SBI) is a purified protein powder enriched in immunoglobulins IgG (55%), IgM (5%), and IgA (1%) used to help manage gut enteropathy. SBI binds a variety of pro-inflammatory antigens and decreases inflammatory markers in the gut by neutralizing or preventing translocation of antigen across the intestinal barrier. The objective of this study is to determine if the immunoglobulins in SBI bind to aflatoxins. Due to the protective effects of SBI, we hypothesize SBI and a highly purified immunoglobulin fraction (>95%), b ovine gamma globulin (BGG), can bind to aflatoxin B2 (AFB2) and aflatoxin G1 (AFG1). Fluorescence spectroscopy was used to quantify the binding of aflatoxins to SBI. Previous work has shown the binding of aflatoxins to tryptophan containing proteins, such as bovine serum albumin, reduces the fluorescence of the protein’s tryptophan residue. The same principle works for SBI, upon excitation at 280 nm, the emission spectra of SBI exhibits a peak at 370 nm which is decreased upon aflatoxin binding. Either SBI (5 μM) or BGG (5 μM) was titrated with an increasing concentration of either AFB2 or AFG1 (0-40 μM). The protein solution was excited at 280 nm and the emission spectra was recorded at 350-450 nm with quenching quantified at 370 nm. The fluorescence from SBI or BGG was reduced in a concentration-dependent manner as the concentration of AFB2 or AFG1 increased. The quenching constant (Ksv) was calculated using the Stern-Volmer equation, while a derivative from the equation was used to calculate the binding constant (Kb). All protein-aflatoxin pairs tested showed binding with Ksv values ranging from 0.9–1.2 x 104 M−1 (R2=0.99) and Kb values ranging from 2.5 x 104 to 4.21 x 105, with SBI-AFB2 exhibiting the tightest binding. Further, the Gibbs free energy for each pair was -6.0 to -7.7 kcal/mol, indicating favorable binding. The quenching of both protein solutions indicates structural and conformational changes in the native structures of both SBI and BGG, likely caused by the interaction of the immunoglobulins with the aflatoxin. The quenching of BGG suggests immunoglobulins in SBI play a significant role for the observed phenomenon, though other serum proteins within SBI could contribute to the quenched fluorescence. Future work will examine if the binding of the aflatoxins by SBI can prevent or mitigate aflatoxin toxicity in the gut. Proliant Health and Biologicals. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Influence of para-substituted benzaldehyde derivatives with different push/pull electron strength groups on the conformation of human serum albumin and toxicological effects in zebrafish

Excessive intake of benzaldehyde and its derivatives can cause irreversible damage to living organisms. Hence, benzaldehyde derivatives with different para-substitutions of push/pull electronic groups were chosen to investigate the effect of different substituent properties on the structure of human serum albumin (HSA). The binding constants, number of binding sites, major interaction forces, protein structural changes, and binding sites of benzaldehyde (BzH) and its derivatives (4-BzHD) with HSA in serum proteins were obtained based on multispectral and molecular docking techniques. The mechanism of BzH/4-BzHD interaction on HSA is mainly static quenching and is accompanied by the formation of a ground state complex. BzH/4-BzHD is bound to HSA in a 1:1 stoichiometric ratio. The interaction forces for the binding of BzH/4-BzHD to HSA are mainly hydrogen bonding and hydrophobic interaction, which are also accompanied by a small amount of electrostatic interactions. The effect of BzH/4-BzHD on HSA conformation follows: 4-Diethylaminobenzaldehyde (4-DBzH) > 4-Nitrobenzaldehyde (4-NBzH) > 4-Hydroxybenzaldehyde (4-HBzH) > 4-Acetaminobenzaldehyde (4-ABzH) > BzH, which means that the stronger push/pull electronic strength of the para-substituted benzaldehyde derivatives has a greater effect on HSA conformation. Furthermore, the concentration-lethality curves of different concentrations for BzH/4-BzHD on zebrafish verified above conclusion. This work provides a scientific basis for the risk assessment of benzaldehyde and its derivatives to the ecological environment and human health and for the environmental toxicological studies of benzaldehyde derivatives with different strengths of push/pull electron substitution.

Serum Proteins Infer Molecular Protection Against Inflammation in Weddell Seal (Leptonychotes weddellii) Blood

Weddell seals ( Leptonychotes weddellii) are elite divers able to dive up to 900 meters deep and remain submerged for over 90 minutes. Weddell seals have a dramatic dive response to allow for longer, deeper dives including intense bradycardia and constriction of blood vessels, especially those supplying peripheral or visceral organs. Vasoconstriction, hypo-perfusion and subsequent re-oxygenation upon surfacing is known to induce tissue injury in terrestrial mammals via inflammation. Previous work interrogating the Weddell seal’s innate immune system suggested a component in the seal’s blood serum that protects against inflammation. We are using a mouse macrophage (RAW 264.7) cell model to characterize components of the seal’s blood that are anti-inflammatory to lipopolysaccharide (LPS). When exposed to 10 ng/mL LPS, RAW cells supplemented with deproteinated serum from adult Weddell seals lose their protection against inflammation, having 11-fold greater induction of interleukin-6 (IL-6) mRNA expression after a 6-h exposure compared to RAW cells supplemented with intact seal serum (T=3.29, p=0.01). To determine whether anti-inflammatory capacity of serum is innately present in Weddell seals or whether it is acquired in conjunction with development of diving capacity, we compared the protective effects of adult Weddell seal serum against serum from Weddell seal pups collected at approximately their age of weaning, when they had begun diving activities but do not yet dive deep. Following exposure to 10 ng/mL LPS, IL-6 expression was 69% lower in RAW cells supplemented with serum from adult seals compared to those supplemented with serum from pups (T=8.41, p=0.002), suggesting that ontogeny or diving behavior contributes to the development of anti-inflammatory serum. Analysis of adult (n=12) and pup (n=11) serum proteomes revealed a single protein, colony stimulating factor 2 receptor subunit beta (CSF2RB), with a 24-fold higher abundance in adults (PFDR<0.0001). CSF2RB is a pleiotropic cell surface receptor subunit with known functions in innate immunity, erythropoiesis, as well as tissue protection. Therefore, we hypothesize that it plays a role in the anti-inflammatory protection observed in adult seals. Defining the mechanism of action for this protein in seal serum could identify a protective adaptation that facilitates deep and long dives. In a broader context, lessons learned from an extreme diving mammals may identify anti-inflammatory strategies with new clinical relevance. NSF #1921491; #1853326; #2337400. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Photoluminescence-based biosensor for the detection of antibodies against SARS-CoV-2 virus proteins by ZnO tetrapod structure integrated within microfluidic system

This paper reports on development of an optical biosensor for the detection of antibodies against SARS-CoV-2 virus proteins in blood serum. ZnO nanotetrapods with high surface area and stable room temperature photoluminescence (PL) were selected as transducers. Structure and optical properties of the ZnO tetrapods have been studied by XRD, SEM and Raman spectroscopy. Crystallinity, dimensions and emission peaks of the ZnO tetrapods were determined. The ZnO tetrapods were fixed on glass chip. Silanization of ZnO tetrapods surface resulted in forming of functional surface groups suitable for the immobilization of bioselective layer. Two types of recombinant proteins (rS and rN) have been used to form bioselective layer on the surface of the ZnO tetrapods. Flow through microfluidic system, integrated with optical system, has been used for the determination of antibodies against SARS-CoV-2 virus proteins present in blood samples. The SARS-CoV-2 probes, prepared in PBS solution, have been injected into the measurement chamber with a constant pumping speed. Steady-state photoluminescence spectra and photoluminescence kinetics have been studied before and after injection of the probes. The biosensor signal has been tested to anti-SARS-CoV-2 antibodies in the range of 0.001 nM–1 nM. Control measurements have been performed with blood serum of healthy person. ZnO-SARS-CoV-2-rS and ZnO-SARS-CoV-2-rN biosensors showed high stability and sensitivity to anti-SARS-CoV-2 antibodies in the range of 0.025–0.5 nM (LOD 0.01 nM) and 0.3–1 nM (LOD 0.3 nM), respectively. Gibbs free energy of interaction between ZnO/SARS-CoV-2-rS and ZnO/SARS-CoV-2-rN bioselective layers with anti-SARS-CoV-2 antibodies showed −35.5 and −21.4 kJ/mol, respectively. Average detection time of biosensor integrated within microfluidic system was 15–20 min. The detection time and pumping speed (50 μL/min) were optimized to make detection faster. The developed system and ZnO-SARS-CoV-2-rS nanostructures have good potential for detection of anti-SARS-CoV-2 antibodies from patient's probes.

Anti-Myelin-associated Glycoprotein Neuropathy

Anti-myelin-associated glycoprotein (MAG) neuropathy, which occurs secondary to immunoglobulin (Ig)M paraproteinemia such as monoclonal gammopathy of undetermined significance, is characterized by slow progression, sensory or sensorimotor disturbances, and ataxia. The estimated prevalence of this neuropathy in Japan is 0.28 per 100,000 population with male preponderance. This neuropathy is diagnosed based on the detection of M protein and anti-MAG antibodies in patients' serum. Nerve conduction studies show prolonged distal latency, and histopathological evaluation of sural nerve biopsies shows widely spaced myelin on electron microscopy. Usually, immunotherapy, including administration of intravenous Ig and corticosteroids, is ineffective, and rituximab is beneficial in approximately 50% of patients. Novel therapies, such as administration of Bruton's tyrosine kinase inhibitors are expected to benefit patients with the MYD88L265P mutation.

The effect of “Teepol” residues on the estimation of serum electrolytes, protein, and cholesterol in sample collection tubes: an interference study

The effect of “Teepol” residues on the estimation of serum electrolytes, protein, and cholesterol in sample collection tubes: an interference study

One year review of serum protein electrophoresis and immunofixation tests performed at a central laboratory in a low-middle income setting: A demand management perspective

One year review of serum protein electrophoresis and immunofixation tests performed at a central laboratory in a low-middle income setting: A demand management perspective

Reporting practices of serum protein electrophoresis in Pakistan – A multicentre survey

Reporting practices of serum protein electrophoresis in Pakistan – A multicentre survey